{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:24Z","timestamp":1794745164803,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119973","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:46:35Z","timestamp":1792147595000},"page":"119973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity"],"prefix":"10.1016","volume":"204","author":[{"given":"Daniel","family":"Da Costa Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"David A.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2026.119973_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and general overview of cyclodextrin chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119973_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics17030288","article-title":"Cyclodextrins: enhancing drug delivery, solubility and bioavailability for modern therapeutics","volume":"17","author":"Nicolaescu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119973_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.podrm.2024.09.003","article-title":"Cyclodextrins and their applications in pharmaceutical and related fields","author":"Khurshid","year":"2025","journal-title":"Profiles Drug. Subst. Excip. Relat. Methodol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119973_bib4","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/molecules30143044","article-title":"Cyclodextrins as multifunctional platforms in drug delivery and beyond: structural features, functional applications, and future trends","volume":"30","author":"Spiridon","year":"2025","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.119973_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics17030288","article-title":"Cyclodextrins: enhancing drug delivery, solubility and bioavailability for modern therapeutics","volume":"17","author":"Nicolaescu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.biopha.2026.119973_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ph18101592","article-title":"Cyclodextrins as active therapeutic agents: beyond their role as excipients","volume":"18","author":"Pirvu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119973_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2025.100232","article-title":"Cyclodextrin-based therapeutics delivery systems: a review of current clinical trials","volume":"9","author":"Hoti","year":"2025","journal-title":"Curr. Res. Pharmacol. Drug. Discov."},{"issue":"3","key":"10.1016\/j.biopha.2026.119973_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.7150\/thno.53459","article-title":"Recent advances in supramolecular antidotes","volume":"11","author":"Yin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119973_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119880","article-title":"Integration of cyclodextrins and associated toxicities: a roadmap for high quality biomedical applications","volume":"295","author":"Trotta","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"22","key":"10.1016\/j.biopha.2026.119973_bib10","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/molecules29225319","article-title":"Cyclodextrins: advances in chemistry, toxicology, and multifaceted applications","volume":"29","author":"Musuc","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2026.119973_bib11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/acn3.306","article-title":"Efficacy and ototoxicity of different cyclodextrins in Niemann\u2013Pick C disease","volume":"3","author":"Davidson","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119973_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49217-8","article-title":"Exploring the role of cyclodextrins as a cholesterol scavenger: a molecular dynamics investigation of conformational changes and thermodynamics","volume":"13","author":"Ganjali Koli","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119973_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00355","article-title":"Cyclodextrins and iatrogenic hearing loss: new drugs with significant risk","volume":"11","author":"Crumling","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119973_bib14","doi-asserted-by":"crossref","first-page":"20269","DOI":"10.3390\/molecules201119694","article-title":"Evaluation of the cytotoxicity of \u03b1-cyclodextrin derivatives on the caco-2 cell line and human erythrocytes","volume":"20","author":"R\u00f3ka","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.119973_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.yrtph.2013.08.013","article-title":"Hydroxypropyl-\u03b2-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog","volume":"67","author":"Rosseels","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119973_bib16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.fct.2011.03.026","article-title":"Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel \u03b2-cyclodextrin derivatives","volume":"49","author":"Wang","year":"2011","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119973_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12011-015-0339-y","article-title":"The RPTEC\/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments","volume":"166","author":"Simon-Friedt","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119973_bib18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/molecules28052283","article-title":"Resazurin reduction-based assays revisited: guidelines for accurate reporting of relative differences on metabolic status","volume":"28","author":"Vieira-da-Silva","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119973_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/B978-0-12-386487-1.00017-1","article-title":"Analysis of cholesterol trafficking with fluorescent probes","author":"Maxfield","year":"2012","journal-title":"Methods Cell. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119973_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/membranes11100779","article-title":"Characterization of extracellular vesicles labelled with a lipophilic dye using fluorescence nanoparticle tracking analysis","volume":"11","author":"Midekessa","year":"2021","journal-title":"Membranes"},{"issue":"1","key":"10.1016\/j.biopha.2026.119973_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13438-5","article-title":"Turnover and flow of the cell membrane for cell migration","volume":"7","author":"Tanaka","year":"2017","journal-title":"Sci. Rep."},{"issue":"D1","key":"10.1016\/j.biopha.2026.119973_bib22","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119973_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.70268","article-title":"The multifaceted significance of phosphoinositides in endocytic trafficking","author":"Xie","year":"2026","journal-title":"FEBS Lett."},{"issue":"2079","key":"10.1016\/j.biopha.2026.119973_bib24","article-title":"Critical factors determining the quantification capability of matrix-assisted laser desorption\/ionization\u2013 time-of-flight mass spectrometry","volume":"374","author":"Wang","year":"2016","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"issue":"51","key":"10.1016\/j.biopha.2026.119973_bib25","doi-asserted-by":"crossref","first-page":"18719","DOI":"10.1021\/acs.analchem.3c02724","article-title":"Toward omics-scale quantitative mass spectrometry imaging of lipids in brain tissue using a multiclass internal standard mixture","volume":"95","author":"Vandenbosch","year":"2023","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119973_bib26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1194\/jlr.D400005-JLR200","article-title":"Cyclodextrins enhance recombinant phosphatidylinositol phosphate kinase activity","volume":"45","author":"Davis","year":"2004","journal-title":"J. Lipid Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226010097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226010097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:54:38Z","timestamp":1794743678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226010097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S0753332226010097"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119973","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119973"}}